AVGO vs DHX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Broadcom exhibits a dichotomy between elite operational performance and poor deterministic value metrics. While the Piotroski F-Score of 4/9 indicates stable health, the stock trades at a massive premium to its Graham Number ($44.08) and Intrinsic Value ($151.04). This valuation gap is partially justified by a very attractive PEG ratio (0.68) and strong forward P/E (19.65), suggesting high growth expectations. However, aggressive insider selling by the CEO and CFO, combined with a bearish technical trend, offsets the strong analyst 'strong_buy' consensus.
DHX exhibits a critically weak deterministic health profile with a Piotroski F-Score of 2/9, signaling significant fundamental deterioration. While the company maintains a strong gross margin (84.66%) and a low debt-to-equity ratio (0.18), it faces severe liquidity constraints evidenced by a current ratio of 0.44. Valuation metrics are attractive with a Price/Sales ratio under 1.0 and a reasonable forward P/E of 13.70, but these are offset by declining year-over-year revenue growth of -10.20%. The stock is a high-risk play where strong earnings beats and analyst optimism clash with deteriorating balance sheet health.
Compare Another Pair
Related Comparisons
AVGO vs DHX: Head-to-Head Comparison
This page compares Broadcom Inc. (AVGO) and DHI Group, Inc. (DHX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.